Patents

US 9322064 B2: Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia

Granted
2016-04-26
Filed
2013-10-23 application 14061206
Type
Utility · 9 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This invention relates generally to the THAP1 gene and mutations in this gene, as well as the THAP1 protein and mutations in this protein, that are associated with dystonia. The invention relates to the identification, isolation, cloning and characterization of the DNA sequence corresponding to the wild type and mutant THAP1 genes, as well as isolation and characterization of their transcripts and gene products. The invention further relates to methods and kits useful for detecting mutations in THAP1 that are associated with dystonia, as well as to methods and kits useful for diagnosing dystonia. The present invention also relates to therapies for treating dystonia, including gene therapeutics and protein/antibody based therapeutics.

Source: PVGPATDIS, file of 2026-04-10 (ipg160426.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Icahn School of Medicine at Mount Sinai 301 patentsUS company or organizationNew York, NYIcahn School of Medicine at Mount Sinai College or university EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10
Beth Israel Medical Center 2 patentsUS company or organizationNew York, NYMount Sinai Phillips School of Nursing College or university EXACT high confidence: through the nonprofit with the college's EIN (identical full name and state)
BETH ISRAEL MEDICAL CENTER Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Laurie OzeliusWhite Plains, NY5PVGPATDIS, file of 2026-04-10
Susan BressmanNew York, NY5PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/6883PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/47PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2014-09-22Government interest
Confirmatory license
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI signed 2014-08-15NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT BETHESDA, MD33793/363ECORSEXC, file of 2026-09-25
2014-01-29Assignment
Icahn school of medicine at mount sinai assigns fifty percent (50%) interest in and to u.s. serial no. 14/061,206 to assignee beth israel medical center.
MOUNT SINAI SCHOOL OF MEDICINE signed 2012-02-13BETH ISRAEL MEDICAL CENTER NEW YORK, NY32141/675ECORSEXC, file of 2026-09-25
2014-01-29Name change
Change of name
MOUNT SINAI SCHOOL OF MEDICINE signed 2012-12-11ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NEW YORK, NY32134/808ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.